DPAM
BMY icon

Degroof Petercam Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Degroof Petercam Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$8.82M Sell
162,600
-105,400
-39% -$5.37M 0.11% 141
2023
Q4 		$13.8M Buy
+268,000
New +$14.1M 0.18% 108

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Degroof Petercam Asset Management's BMY Position: Q1 2024 in Review

Degroof Petercam Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 39% in Q1 2024, selling an estimated $5.37M and leaving 162,600 shares worth $8.82M. The position accounts for 0.11% of the portfolio, ranked #141.

Degroof Petercam Asset Management first reported a position in BMY in Q4 2023 and has held it in 2 quarters since. The position peaked at $13.8M in Q4 2023. 2,334 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Degroof Petercam Asset Management held 162,600 shares of Bristol-Myers Squibb worth $8.82M as of Q1 2024.
  • Degroof Petercam Asset Management sold 105,400 Bristol-Myers Squibb shares in Q1 2024, an estimated $5.37M.
  • Bristol-Myers Squibb made up 0.11% of Degroof Petercam Asset Management's portfolio in Q1 2024, its #141 holding.
  • Degroof Petercam Asset Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 2 quarters since.
  • Degroof Petercam Asset Management's Bristol-Myers Squibb position peaked at $13.8M in Q4 2023.
  • 2,334 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Degroof Petercam Asset Management's 13F filing for Q1 2024, filed 13 May 2024.